DD211714A5 - Verfahren zur isolierung von carcinoembryonalem antigen - Google Patents

Verfahren zur isolierung von carcinoembryonalem antigen Download PDF

Info

Publication number
DD211714A5
DD211714A5 DD83253901A DD25390183A DD211714A5 DD 211714 A5 DD211714 A5 DD 211714A5 DD 83253901 A DD83253901 A DD 83253901A DD 25390183 A DD25390183 A DD 25390183A DD 211714 A5 DD211714 A5 DD 211714A5
Authority
DD
German Democratic Republic
Prior art keywords
cea
column
fraction
buffer
proteins
Prior art date
Application number
DD83253901A
Other languages
German (de)
English (en)
Inventor
Rolf Lamerz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DD211714A5 publication Critical patent/DD211714A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A61K39/001182—Carcinoembryonic antigen [CEA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD83253901A 1982-08-14 1983-08-11 Verfahren zur isolierung von carcinoembryonalem antigen DD211714A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823230299 DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Publications (1)

Publication Number Publication Date
DD211714A5 true DD211714A5 (de) 1984-07-25

Family

ID=6170888

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83253901A DD211714A5 (de) 1982-08-14 1983-08-11 Verfahren zur isolierung von carcinoembryonalem antigen

Country Status (13)

Country Link
EP (1) EP0102008A3 (enExample)
JP (1) JPS5950360A (enExample)
AU (1) AU1796083A (enExample)
DD (1) DD211714A5 (enExample)
DE (1) DE3230299A1 (enExample)
DK (1) DK368783A (enExample)
ES (1) ES8404187A1 (enExample)
FI (1) FI832899A7 (enExample)
GR (1) GR78692B (enExample)
IL (1) IL69476A0 (enExample)
NO (1) NO832905L (enExample)
PT (1) PT77199B (enExample)
ZA (1) ZA835947B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine

Also Published As

Publication number Publication date
GR78692B (enExample) 1984-09-27
ES524909A0 (es) 1984-05-01
ZA835947B (en) 1984-04-25
DK368783D0 (da) 1983-08-12
ES8404187A1 (es) 1984-05-01
FI832899L (fi) 1984-02-15
AU1796083A (en) 1985-02-21
JPS5950360A (ja) 1984-03-23
EP0102008A3 (de) 1987-01-28
IL69476A0 (en) 1983-11-30
EP0102008A2 (de) 1984-03-07
PT77199A (de) 1983-09-01
DE3230299A1 (de) 1984-02-16
PT77199B (de) 1986-03-27
NO832905L (no) 1984-02-15
DK368783A (da) 1984-02-15
FI832899A0 (fi) 1983-08-11
FI832899A7 (fi) 1984-02-15

Similar Documents

Publication Publication Date Title
CH634334A5 (de) Neues glycoprotein und verfahren zu dessen herstellung.
EP0000134B1 (de) Glykoprotein, Verfahren zu seiner Herstellung, seine Verwendung zur Gewinnung von Antiserum sowie das Antiserum
DE2801257A1 (de) Brustkrebs-bezogene antigene, verfahren zu ihrer extraktiven gewinnung und ihre verwendung
Dinh et al. Immunochemical study on rat urinary proteins: their relation to serum and kidney proteins (chromatographic separation of the major urinary protein)
EP0100522B1 (de) Neues Protein (PP17), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0101603B1 (de) Neues Protein (PP13), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0037963B1 (de) Neues Protein PP9, Verfahren zu seiner Gewinnung sowie seine Verwendung
EP0014756A1 (de) Plazentaspezifisches Gewebsprotein PP10 und Verfahren zu seiner Anreicherung
Stelos et al. Heterogeneity of Rabbit Antibody Frangments
EP0165476A2 (de) Gewebeprotein PP18, Verfahren zu seiner Gewinnung sowie seine Verwendung
EP0141326B1 (de) Neues Protein PP20, Verfahren zu seiner Gewinnung sowie seine Verwendung
EP0029191B1 (de) Neues Protein PP11, ein Verfahren zu seiner Gewinnung und seine Verwendung
CH632091A5 (en) Process for the preparation of an antiserum directed against placenta-specific glycoprotein
DD211714A5 (de) Verfahren zur isolierung von carcinoembryonalem antigen
DE3780256T2 (de) Anti-pci-monoklonaler antikoerper.
Fahey et al. Separation of 6.6 S and 18S gamma globulins with isohemagglutinin activity
O'Donnell et al. Microvillar iron-binding glycoproteins isolated from the rabbit small intestine
EP0137345B1 (de) Membranassoziierte Proteine (MP2), Verfahren zu ihrer Gewinnung sowie ihre Verwendung
DE2353973C3 (de) Steroid-bindendes Globulin und Verfahren zu dessen Herstellung
DE3410694C2 (enExample)
EP0151463B1 (de) Gewebeprotein PP19, Verfahren zu seiner Gewinnung sowie seine Verwendung
Stiehm et al. Some immunologic properties of papain digest fragments of multiple myeloma proteins
Matsuoka et al. Isolation and characterization of IgA produced by an established human lymphocytoid cell line
Groth et al. Purification and characterisation of the fourth component of bovine complement
DE68916088T2 (de) Anti-CPBII-monoklonaler Antikörper.